title: Recombinant erythropoietin for refractory anemia with ring sideroblasts.
authors.forename: P
authors.initials: P
authors.lastname: Musto
authors.forename: L
authors.initials: L
authors.lastname: Catalano
authors.forename: A
authors.initials: A
authors.lastname: Andriani
authors.forename: C
authors.initials: C
authors.lastname: Bodenizza
authors.forename: N
authors.initials: N
authors.lastname: Cascavilla
authors.forename: N
authors.initials: N
authors.lastname: Di Renzo
authors.forename: L
authors.initials: L
authors.lastname: Melillo
authors.forename: L
authors.initials: L
authors.lastname: Cicoira
authors.forename: M
authors.initials: M
authors.lastname: Carotenuto
authors.forename: B
authors.initials: B
authors.lastname: Rotoli
mesh_terms: D000368:Aged; D000754:Anemia, Refractory, with Excess of Blasts / Q000628:therapy*; D000756:Anemia, Sideroblastic / Q000628:therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D006454:Hemoglobins; D007155:Immunologic Factors; D011994:Recombinant Proteins; D004921:Erythropoietin